Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 34813-49-5 | MDL No. : | MFCD02179404 |
Formula : | C4H11NO2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GWJSQKNYHPYZRN-UHFFFAOYSA-N |
M.W : | 137.20 | Pubchem ID : | 2757335 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 33.05 |
TPSA : | 68.54 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.2 cm/s |
Log Po/w (iLOGP) : | 0.51 |
Log Po/w (XLOGP3) : | -0.09 |
Log Po/w (WLOGP) : | 1.15 |
Log Po/w (MLOGP) : | -0.5 |
Log Po/w (SILICOS-IT) : | -0.83 |
Consensus Log Po/w : | 0.05 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.57 |
Solubility : | 37.1 mg/ml ; 0.27 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.9 |
Solubility : | 17.4 mg/ml ; 0.127 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.63 |
Solubility : | 32.4 mg/ml ; 0.236 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.24 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
350 mg | With ammonia In tetrahydrofuran at -50 - 35℃; for 16 h; | Ammonia gas was purged into t-butylsulfonyl chloride (500 mg, 3.2 mmol) in THF (5 mL) at -50°C for 15 minutes and stirring was continued at 20-35 °C for 16 h. The solid precipitate obtained was filtered; the filtrate collected was concentrated under reduced pressure to afford 350 mg of the title compound. 1H NMR (400 MHz, DMSO- d6) δ ppm 6.71 (2H, bs), 1.38 (9H, s). |
350 mg | With ammonia In tetrahydrofuran at -50 - 35℃; for 16 h; | Ammonia gas was purged into t-butylsulfonyl chloride (500 mg, 3.2 mmol) in THF (5 mL) at -50° C. for 15 minutes and stirring was continued at 20-35° C. for 16 h. The solid precipitate obtained was filtered; the filtrate collected was concentrated under reduced pressure to afford 350 mg of the title compound. 1H NMR (400 MHz, DMSO-d6) δ ppm 6.71 (2H, bs), 1.38 (9H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 3-chloro-benzenecarboperoxoic acid; In dichloromethane; at 20℃; for 0.0833333h; | To a solution of the tert-butylsulfinamide in CH2Cl2 (6 mL), commercial m-CPBA(1.5 equiv.) was added in one portion at r.t. When the reaction was complete (5 min),40% sodium bisulfite (5 mL) was added and the mixture was stirred for 5 min. Thesolution was extracted with CH2Cl2 (3×20 mL), the organic phase was washed withsaturated sodium bicarbonate (2×40 mL), dried (Na2SO4), and concentrated. Thecorresponding sulfonamide was obtained pure in most cases; when not, it was purifiedby column chromatography. 1H NMR (500 MHz, CDCl3) delta 3.73 (s, 2H), 1.24 (s, 9H).13C NMR (125 MHz, CDCl3) delta 55.32, 22.13. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 0 - 60℃; | Step 4: N-(3-dijnethykmmopropyl)-N-ethyJcaiixxIiimid(i hydrochloride {0.23 rmrifiD Ls added to a shred ice cold soimi°n of 2-^lV{6'|2~(2,4"dtchlor°-phenyi3-eyianlambdaino]-2-metlloxyiJyrimidin-4y. ^-phertgamma^^2- f5.e5ily^propioj).^: acid (0,22 mrnoi), ^rr-busyisu.fotauiamjdc (0,23 mmol) and 4"dimet[ybfniiK)pyri<line i n i'0.22 ntj-?oi) ia dry DCM under nitrogen aSmophihere. The ice bath is removed and the reaction rrsixUiic is ?stira-d uver?ighs at 6O0C. The voiatsles nre removed under educed pressure, ihs residue is dissolved h- eShyl acetate, washed with 0.1 N HCl. brine and water, dried over sodium surf°to, fikered and concenirated under reduced pressure, The crude residue is. purified by chros?atalphagraphy (SKi1 packed column ., eluting witli EsOAc / DCM to afford 2-nrethyi-j>ropaoe-2-sulfonic acid s 3-beta -. 6- 12-; 2.4-dichk?m:-phenyl V dMiajnint^-S^n^tjioxx-pjiiinijdio^^ taung'j. LCMS: R-E -- 2.6? ?jiiujtes, MS: 579, 5S i CM +H). IC%, ~- 2 nM. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
4% | With iodosylbenzene;iron(III)-acetylacetonate; In acetonitrile; at 20℃; for 250h; | EXAMPLE 22 (RS)-S-{4-[(5-Bromo-4-[(R)-2-hydroxy-1,2-dimethylpropyl]amino}pyrimidin-2-yl)amino]phenyl}-N-(tert-butylsulphonyl)-S-methylsulphimide Preparation of the Final ProductProduct 250 mg (0.63 mmol) of (R)-3-[{5-bromo-2-(4-methylsulphanylphenylamino) pyrimidin-4-yl)}amino]-2-methylbutan-2-ol (compound 9.1), 129 mg (0.94 mmol) of tert-butylsulphonamide, 221 mg (1.01 mmol) of iodosobenzene and 222 mg (0.63 mmol) of iron(III)acetylacetonate are weighed into a flask, and 6 ml of acetonitrile are added. The mixture is stirred at room temperature for 250 hours and then concentrated in a rotary evaporator. The remaining residue is purified by chromatography (dichloromethane/ethanol 8:2). 15 mg (0.03 mmol; yield: 4%) of the product are obtained. 1H-NMR (DMSO): 9.74 (s, 1H), 8.09 (s, 1H), 7.92 (m, 2H), 7.74 (m, 2H), 6.11 (d, 1H), 4.04 (m, 1H), 2.94 (s, 3H), 1.11 (m, 18H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In DMF (N,N-dimethyl-formamide); | A mixture of 2-methylpropane-2-sulfonamide (58 mg, 0.4 mmol), added acid 1 (40 mg, 0.08 mmol), DMAP (54 mg, 0.44 mmol), N1-((ethylimino)methylene)-N3,N3-dimethylpropane-1,3-diamine hydrochloride (41 mg, 0.21 mmol) in DMF (1.5 mL) was stirred o/n and purified by prep HPLC to afford the product as a solid (3.5 mg, 7%). 1H NMR (400 MHz, CHLOROFORM-D) delta ppm 1.12-1.58 (m, 4 H) 1.58 (s, 9 H) 1.67-2.19 (m, J=120.61 Hz, 5 H) 2.82 (s, 1 H) 3.05-3.76 (m, 10 H) 4.37 (s, 1 H) 5.06 (s, 1 H) 6.85 (s, 1 H) 7.34-7.60 (m, 4 H) 7.83-7.97 (m, 1 H) 8.08 (s, 1 H) LC-MS (retention time: 3.02; MS m/z 590 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With titanium tetrachloride; triethylamine; In dichloromethane; 1,2-dichloro-ethane; at 20℃; for 6.5h;Heating / reflux; | Triethylamine (6 mL, 43.2 mmol) was added to a stirred suspension of 11- oxo-5, 6,7, 8,9, 10-hexahydro-2-nitro-6,9-methanobenzocyclooctene (5.0 g, 21.6 mmol; J. Org. Chem. 47,4329, 1982), tert-butyl sulphonamide (2.97 g, 21.6 mmol) and titanium (IV) chloride (1.0 M in dichloromethane, 13 mL, 13 mmol) in 1,2-dichloroethane (50 mL) at room temperature under nitrogen. The reaction was heated under reflux for 6.5 hours then allowed to cool to room temperature. The reaction mixture was poured into water (250 mL), hydrochloric acid (2 M, 100 mL) and dichloromethane (200 mL) and filtered through Celite (E). The layers were separated and the organic layer washed with brine, dried over Na2SO4 and concentrated to give the imine (6. 85 g containing 5% starting nitroketone, 87% yield of imine). MS (ES+) 231 ([MH] +). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With titanium tetrachloride; triethylamine; In dichloromethane; 1,2-dichloro-ethane; at 20℃; for 8.5h;Heating / reflux; | A solution of titanium (IV) chloride (25 mL, 1M in DCM) was added at r. t. to a stirred suspension of the ketone from Step 1 (10.0 g), tert-butyl sulfonamide (5.8 g) and triethylamine (11.6 mL) in 1,2-dichloroethane (100 mL). The yellow suspension was stirred under nitrogen for 30 minutes, then refluxed for 8 hours. The mixture was diluted with dichloromethane (400 mL) and saturated aqueous sodium hydrogencarbonate (400 mL) and filtered through a pad of Celite. The organic phase was dried (Na2SO4), filtered and concentrated to give the sulfonimine (15.5 g, quantitative) as a brown gum. No. (1H, 360MHz, CDCl3) 1.20-1. 40 (2H, m), 1.50 (9H, s), 1.75- 2.00 (2H, m), 2.90-2. 95 (2H, m), 3.05-3, 20 (3H, m), 3.92 (3H, s), 3.95-4. 05 (1H, m), 7.24-7. 28 (1H, m), 7.84-7. 87 (2H, m). |
100% | With titanium tetrachloride; triethylamine; In dichloromethane; 1,2-dichloro-ethane; at 20℃; for 8.5h;Heating / reflux; | A solution of titanium (IV) chloride (25 mL, 1M in DCM) was added at r. t. to a stirred suspension of the ketone from Step 1 (10.0 g), tert-butyl sulfonamide (5.8 g) and triethylamine (11.6 mL) in 1,2-dichloroethane (100 mL). The yellow suspension was stirred under nitrogen for 30 minutes, then refluxed for 8 hours. The mixture was diluted with dichloromethane (400 mL) and saturated aqueous sodium hydrogencarbonate (400 mL) and filtered through a pad of Celite. The organic phase was dried (Na2SO4), filtered and concentrated to give the sulfonimine (15.5 g, quantitative) as a brown gum. 8 (iH, 360MHz, CDCl3) 1.20-1. 40 (2H, m), 1.50 (9H, s), 1.75- 2.00 (2H, m), 2.90-2. 95 (2H, m), 3.05-3, 20 (3H, m), 3.92 (3H, s), 3.95-4. 05 (1H, m), 7.24-7. 28 (1H, m), 7.84-7. 87 (2H, m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
titanium(IV) tetraethanolate; In hexane; ethyl acetate; | A solution of <strong>[34813-49-5](S)-(-)-<strong>[34813-49-5]2-methyl-2-propanesulfonamide</strong></strong> (500 mg, 4.1 mmol), 4-methyl-2-hexanone (470 mg, 4.1 mmol), and Titanium(IV) ethoxide (1.7 mL, 8.3 mmol) was heated at reflux for 18 h. The reaction mixture was poured into 20 mL brine with rapid stirring. The resulting solution was filtered through celite, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2*20 mL). The combined organics were dried (Na2SO4), filtered, and concentrated. The resultant oil was purified by silica gel chromatography (25% EtOAc in hexane) to give 575 mg of 2-Methyl-propane-2(S)-sulfinic acid (1,3-dimethyl-pentylidene)-amide as a yellow oil. 3,5-Dimethyl-3-(2-methyl-propane-2(S)-sulfinylamino)-heptanoic acid methyl ester: | |
titanium(IV) tetraethanolate; In hexane; ethyl acetate; | A solution of <strong>[34813-49-5](S)-(-)-<strong>[34813-49-5]2-methyl-2-propanesulfonamide</strong></strong> (500 mg, 4.1 mmol), 4-methyl-2-hexanone (470 mg, 4.1 mmol), and Titanium(IV) ethoxide (1.7 mL, 8.3 mmol) was heated at reflux for 18 h. The reaction mixture was poured into 20 mL brine with rapid stirring. The resulting solution was filtered through celite, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2*20 mL). The combined organics were dried (Na2SO4), filtered, and concentrated. The resultant oil was purified by silica gel chromatography (25% EtOAc in hexane) to give 575 mg of 2-Methyl-propane-2(S)-sulfinic acid (1,3-dimethyl-pentylidene)-amide as a yellow oil. 3,5-Dimethyl-3-(2-methyl-propane-2(S)-sulfinylamino)-heptanoic acid methyl ester: |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | Step 4: 1,1-Dimethylethylsulphonamide : To a refluxing solution of 1,1-dimethylethylsulphinamide (0.5g, 4.1mmol) in anhydrous acetone (25ml) was added dropwise a saturated solution of potassium permanganate in acetone (40ml) over a period of 1h, until a purple colour persisted. The mixture was refluxed for a further 30 min and the precipitate was removed by hot filtration. The precipitate was washed well with further acetone and the filtrate evaporated in vacuo. The resultant yellow solid was triturated with petrol and the precipitate was collected by filtration to give the title compound (0.32g, 57%) as a colourless solid. mp 160-162C. 1H NMR (360MHz, D6-DMSO) delta 1.27 (9H, s), 6.58 (2H, brs). | |
0.20 g (52%) | Part E. 1-[4-methoxyphenyl]-3-(methoxycarbonyl)-6-[2'-aminosulfonyl-3-fluoro-[1,1']-biphen-4-yl]-1,6-dihydropyrazolo-[4,3-d]-pyrimidin-7-one. 1-[4-methoxyphenyl]-3-(methoxycarbonyl)-6-[2-fluoro-4-bromophenyl]-1,6-dihydropyrazolo-[4,3-d]-pyrimidin-7-one (0.30 g, 0.633 mmol), TBAB (0.02 g, 0.06 mmol), aqueous Na2CO3 (2M, 0.7 mL, 0.88 mmol), and 2-(N-tert-butyl)phenylsulfonamide boronic acid (0.22 g, 0.88 mmol) were dissolved in 100 mL of benzene and degassed with nitrogen for 30 minutes. Following the purge, tetrakis(triphenylphosphine)palladium(0) (0.036 g, 0.03 mmol) was added and the solution stirred overnight at reflux. The solution was diluted with EtOAc and washed twice with brine and the organics dried over MgSO4, filtered and the volatiles were removed under reduced pressure. Purification by column chromatography, eluding with 1:1 hexane/EtOAc, afforded 0.20 g (52%) of a tert-butyl sulfonamide. This compound (0.20 g, 0.33 mmol) was dissolved in 25 mL of TFA and refluxed for 1 hour. | |
0.2 g (52%) | Part F. 1-[4-methoxyphenyl]-3-(methoxycarbonyl)-6-[2'-aminosulfonyl-[1,1']-biphen-4-yl]-1,6-dihydropyrazolo-[4,3-d]-pyrimidin-7-one. A solution of 1-[4-methoxyphenyl]-3-(methoxycarbonyl)-6-[4-bromophenyl]-1,6-dihydropyrazolo-[4,3-d]-pyrimidin-7-one (0.60 g, 1.32 mmol), TBAB (0.04 g, 0.13 mmol), aqueous Na2CO3 (2M, 2.6 mL, 5.28 mmol), and 2-(tert-butylaminosulfonyl)phenylboronic acid (0.47 g, 1.84 mmol) in 100 mL of benzene was degassed with a stream of nitrogen for 30 minutes. Following the purge, tetrakis(triphenylphosphine)palladium(0) (0.076 g, 0.066 mmol) was added and the solution was stirred overnight at reflux. The solution was diluted with EtOAc and washed twice with brine and the organics dried over MgSO4, filtered and the volatiles removed under reduced pressure. The residue was purified by column chromatography (elution with 1:1 hexane/EtOAc) to afford 0.2 g (52%) of a t-butylsulfonamide. A portion of this compound (0.08g, 0.136 mmol) was dissolved in 30 mL of TFA and refluxed for 1 hour. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14.5 g (74%) | In water; ethyl acetate; acetonitrile; | Sodium azide (16.2 g, 249 mmol) was suspended in 100 mL of acetonitrile and 10 mL of water was added to the suspension. The mixture was heated to just below the boiling point of acetonitrile, the source of heat was removed and t-butylsulfonyl chloride (20 g, 142 mmol) was added slowly while the reaction mixture was being vigorously stirred. The reaction is highly exothermic, and the addition rate was adjusted as to maintain gentle reflux of acetonitrile. After the addition was complete, the reaction mixture was allowed to cool to room temperature. Ethyl acetate (50 mL) and water (40 mL) were added and the layers were separated. The aqueous layer was extracted once with ethyl acetate, the combined organic layers were washed with water and dried with MgSO4. After the solvents were evaporated in vacuo, the residue was mixed with ether and the crystals were filtered and washed with ether. The product was recrystallized from acetone to afford 14.5 g (74%) of t-butylsulfonamide as white crystals (m.p. 161-163 C., lit. 162-165 C. (Hovius et al. Tetrahedron Lett. 1972, 181). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49% | In acetonitrile; | By using a similar procedure, but replacing the aqueous ammonia/ether by three equivalents of t -butylamine in acetonitrile (at 0oC) the t -butylsulfonamide was produced in 49% yield. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; | A mixture of 2-methylpropane-2-sulfonamide (58 mg, 0.4 mrnol), added acid 1 (40 mg, 0.08 mmol), DMAP (54 mg, 0.44 mmol), Nl-((ethylimino)methylene)- N3,N3-dimethylpropane-l,3-diamine hydrochloride (41 mg, 0.21 mmol) in DMF (1.5 mL) was stirred o/n and purified by prep HPLC to afford the product as a solid (3.5 mg, 7 %).IH NMR (400 MHz, CHLOROFORM-D) 6 ppm 1.12 - 1.58 (m, 4 H) 1.58 (s, 9 H) 1.67 - 2.19 (m, J=I 20.61 Hz, 5 H) 2.82 (s, 1 H) 3.05 - 3.76 (m, 10 H) 4.37 (s, 1 H) 5.06 (s, 1 H) 6.85 (s, 1 H) 7.34 - 7.60 (m, 4 H) 7.83 - 7.97 (m, 1 H) 8.08 (s, 1 H) LC- MS (retention time: 3.02; MS m/z 590 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | Example 10: 2-Methyl-propane-2-sulfonic acid {(S)-3-[l-(l,4-dimethyl-lH- indol-3-ylmethyl)-2-oxo-l,2-dihydro-imidazo[4,5-b]pyridin-3-yl]-hexanoyl}- amideTHF (S)-3-[l-(l,4-Dimethyl-lH-indol-3-ylmethyl)-2-oxo-l,2-dihydro-imidazo[4,5- b]pyridin-3-yl]-hexanoic acid is synthesized as in example 1. (S)-3-[l-(l,4-Dimethyl-lH-indol-3-ylmethyl)-2-oxo-l,2-dihydro-imidazo[4,5- b]pyridin-3-yl]-hexanoic acid (85 mg, 0.21 mmol) was dissolved in THF (1.0 mL) and CDI (76 mg, 0.47 mmol) was added at room temperature. The mixture was heated at 55 0C for 1 hour. After the mixture is cooled down to room temperature, <strong>[34813-49-5]2-methyl-propane-2-sulfonic acid amide</strong> (57 mg, 0.42 mmol) was added and after 10 min, DBU (0.063 mL, 0.42 mmol) was added. The mixture was stirred for 16 hours at room temperature. Then 2.0 mL of 1.0 M HCl was added followed by 30 mL of water. The mixture is extracted with EtOAc (3 x 20 mL) and the organic layers were combined, dried and concentrated to give crude product. Purification first by flash column chromatography using 5% MeOH in CH2CI2 then by preparative TLC (6% MeOH in CH2Cl2 with 1% concentrated NH4OH) afforded 79 mg (71%) of the title compound. LCMS, M++l, m/z: 526.13. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
24% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; | Example 86 4-(2-Methyl-propane-2-sulfonylaminocarbonyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid (4-iodo-3-methyl-phenyl)-amide. A suspension of 5'-(4-iodo-3-methyl-phenylcarbamoyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid (50 mg, 0.11 mmol) in CH2Cl2 (5 mL) was treated with EDCI (60 mg, 0.31 mmol), t-butyl sulfonamide (18 mg, 0.13 mmol) and a catalytic amount of DMAP. After stirring at rt overnight the mixture was partitioned between CH2Cl2 and water. The CH2Cl2 layer was then collected and evaporated. The product was isolated after a purification with a silica gel column and 2-5% MeOH in CH2Cl2 and a precipitation out of warm CH2Cl2 with excess of hexanes (15 mg, Yield:24%). HRMS m/z calcd for C23H29N4O4SI [M+H]+: 585.1027; Found: 585.1032. |
24% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride;dmap; In dichloromethane; at 20℃; | A suspension of 5'-(4-iodo-3-methyl-phenylcarbamoyl)-3,4,5,6-tetrahydro-2H-[1,4]bipyridinyl-4-carboxylic acid (50 mg, 0.11 mmol) in CH2Cl2 (5 mL) was treated with EDCI (60 mg, 0.31 mmol), t-butyl sulfonamide (18 mg, 0.13 mmol) and a catalytic amount of DMAP. After stirring at rt overnight the mixture was partitioned between CH2Cl2 and water. The CH2Cl2 layer was then collected and evaporated. The product was isolated after a purification with a silica gel column and 2-5% MeOH in CH2Cl2 and a precipitation out of warm CH2Cl2 with excess of hexanes (15 mg, Yield: 24%). HRMS m/z calcd for C23H29N4O4SI [M+H]+: 585.1027; Found: 585.1032. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dicyclohexyl-carbodiimide;dmap; In dichloromethane; at 30℃; for 3h; | Example 11 1 N-{4-[(3,5-Dimethyl-4-[(2-methylpropane-2-sulfonyl)carbamoyl]methyl}-1 H-pyrazol-1 - yl)methyl]phenyl}-4-(trifluoromethyl)benzamide{3,5-Dimethyl-1 -[4-(4-trifluoromethyl-benzoylamino)-benzyl]-1 H-pyrazol-4-yl}-acetic acid (example 1.1 , 250 mg, 0.58 mmol), 2-methylpropane-2-sulfonamide (95 mg, 0.70 mmol), 1 ,3-dicyclohexylcarbodiimid (143 mg, 0.70 mmol) and 4-dimethylaminopyridine (85 mg, 0.70 mmol) in 2.5 ml dichloromethane were stirred for 3 h at 30C. The solvent was removed under reduced pressure and the residue was purified by MPLC (silica gel, CH2Cl2/methanol 95:5). Yield: 51 mgESI mass spectrum: [M+H]+ = 551Retention time HPLC: 1 .34 min (method D). | |
With dmap; dicyclohexyl-carbodiimide; In dichloromethane; at 30℃; for 3h; | Example 11.1N-{4-[(3,5-Dimethyl-4-[(2-methylpropane-2-sulfonyl)carbamoyl]methyl}-1H-pyrazol-1-yl)methyl]phenyl}-4-(trifluoromethyl)benzamide{3,5-Dimethyl-1-[4-(4-trifluoromethyl-benzoylamino)-benzyl]-1H-pyrazol-4-yl}-acetic acid (example 1.1, 250 mg, 0.58 mmol), 2-methylpropane-2-sulfonamide (95 mg, 0.70 mmol), 1,3-dicyclohexylcarbodiimid (143 mg, 0.70 mmol) and 4-dimethylaminopyridine (85 mg, 0.70 mmol) in 2.5 ml dichloromethane were stirred for 3 h at 30 C. The solvent was removed under reduced pressure and the residue was purified by MPLC (silica gel, CH2Cl2/methanol 95:5).Yield: 51 mgESI mass spectrum: [M+H]+=551Retention time HPLC: 1.34 min (method D). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In 1,2-dichloro-ethane; N,N-dimethyl-formamide; at 20℃; | In a 1 dram vial with stir bar were combined 3- (2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-5-yl)benzoic acid (35 mg, 0.090 mmol), DMAP (33 mg, 0.27 mmol), EDC hydrochloride (26 mg, 0.14 mmol), and ter<strong>[34813-49-5]t-butylsulfonamide</strong> (37 mg, 0.27 mmol). 1 ,2-Dichloroethane (1 mL) and DMF (0.3 mL) were added, the vial was capped, and the reaction was stirred at r.t.overnight. The reaction was concentrated, filtered, purified by prep HPLC, and concentrated on a speedvac to give 14 mg (31% yield) of the title compound as a white powder. XH NMR (500 MHz, CDC13) delta ppm 8.12 (s, 1 H) 7.97 (s, 1 H) 7.91 (dd, J= 8.55, 5.19 Hz, 2 H) 7.84 (d, J= 7.63 Hz, 1 H) 7.79 (d, J= 7.32 Hz, 1 H) 7.46 - 7.59 (m, 3 H) 7.19 (t, J= 8.55 Hz, 2 H) 6.04 (br. s., 1 H) 2.99 (d, J= 4.58 Hz, 3 H) 1.54 (s, 9 H). LC/MS was performed by using Shimadzu-VP instrument with UV detection at 220 nm and Waters Micromass. LC/MS method: solvent A = 10% CH3CN/90% H2O/0.1% TFA, solvent B = 90% CH3CN/10%H2O/0.1% TFA, start %B = 0, final %B = 100, gradient time = 2 min, stop time = 3 min, flow rate = 4 ml/min, column: Sunfire C18 5 muiotaeta 4.6 x 50 mm; HPLC Rt = 1.71 min, (ES+) m/z (MH ) = 509. Analytical HPLC were performed using a Shimadzu-VP instrument with UV detection at 220 nm and 254 nm. Analytical HPLC method: solvent A = 5% CH3OH/95% H2O/10 mM NH4HC03, solvent B = 95% CH3OH/5% H2O/10 mM NH4HC03, start %B = 10, final %B = 100, gradient time = 15 min, stop time = 18 min, flow rate = 1 ml/min. Column: Phenomenex Gemini CI 8, 4.6 mm, 3 muiotaeta, Rt = 16.49 min, purity = 100%; column: Waters Xbridge Phenyl 4.6 x 150 mm, 3.5 muiotaeta, Rt = 15.35 min, purity = 100%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | With copper(l) iodide; potassium carbonate; N,N`-dimethylethylenediamine; In acetonitrile; at 80℃; for 36h;Inert atmosphere; | General procedure: Inside a N2 filled glovebox, benzenesulfonamide (250 mg, 1.590 mmol) and copper(I) iodide (15.14 mg, 0.080 mmol), 4-toluene bromide (326mg, 1.91 mmol), potassium carbonate (550 mg, 3.98 mmol), Acetonitrile (4 mL), and N1,N2dimethylethane-1,2-diamine (70.1 mg, 0.795 mmol) was charged into a vial. The vial was then heated to 70 oC for 8hr, LC indicated >97% conversion of benzenesulfonamide. The reaction mixture was then cooled to room temperature. 2N HCl (4mL) was added slowly, followed by EtOAc extraction (5mL x 3). The organic layers were combined, concentrated, and flash chromatographed (SiO2, 20:1--> 3:1 Heptane:EtOAc) to give N(p-tolyl) benzene sulfonamide as white solids (380 mg, 97%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | General procedure: A suspension of potassium hydride (3 equiv) in THF (0.6 M) was cooled in an ice-water bath. A solution of sulfonamide, sulfonamide or aniline (1.0 equiv) in THF (0.20 M) was added dropwise, and the suspension was stirred for 15 min. 1,1'-Carbonyldiimidazole (1.0 equiv) was dissolved in 1:1 THF/dioxane (0.20 M) and added dropwise to the reaction mixture, resulting in the formation of a white precipitate. The ice-water bath was removed, and the reaction mixture was allowed to warm to ambient temperature and was stirred for 2 h. A solution of diamine S-1 (1.0 equiv) in THF (1.0 M) was added dropwise, and the suspension was stirred at room temperature for 20 h. The reaction was quenched with a solution of acetic acid (3 equiv) in THF (1.0 M). The crude product was concentrated in vacuo and purified by silica gel chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13.1 g (65.5%) | In tetrahydrofuran; hexane; ethyl acetate; | e) N-(1-(5-bromo-2-fluorophenyl)-3-(tert-butyldimethylsilyloxy)-2,2-difluoropropylidene)-2-methylpropane-2-sulfinamide To a solution of 1-(5-bromo-2-fluorophenyl)-3-(tert-butyldimethylsilyloxy)-2,2-difluoropropan-1-one (16.0 g, 40.4 mmol) in dry THF (350 mL) was added Ti(OEt)4 (16.7 mL, 80.4 mmol) and 2-Methyl-2-propane sulfonamide (5.8 g, 48.4 mmol) and refluxed for 16 h. Reaction mixture was concentrated under reduced pressure and the crude residue was directly purified by column chromatography on silica gel with 3% ethyl acetate in Hexane to furnish title compound as a colorless liquid. Yield=13.1 g (65.5%). TLC (10% ethyl acetate in Hexane): Rf=0.2), LCMS RtH8=2.29 [M+H]+=499.9, 501.8, 1H NMR (300 MHz, CDCl3) delta 7.48-7.29 (m, 2H, 6.98 (m, 1H), 4.10 (t, 1H), 1.23 (d, 9H), 0.96 (d, 9H), 0.5 (d, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With titanium(IV) tetraethanolate; In tetrahydrofuran; at 65℃; for 16h; | To a solution of 3-bromo-benzaldehyde (1.27 mL, 10.8 mmol) in THF (50 mL) were added titanium(IV) ethoxide (0.786 mL, 21.6 mmol) and ter<strong>[34813-49-5]t-butylsulfonamide</strong> (1.31 g, 10.8 mmol), and stirring was continued for 16 h at 65C. After cooling to RT, volatiles were evaporated, and the residue was purified by flash column chromatography on silica gel (c-hexane/EtOAc 3: 1) to afford the title compound. MS (LC/MS): 289 [M+H]+; tR (HPLC conditions f): 2.35 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65.5% | With titanium(IV) tetraethanolate; In tetrahydrofuran; hexane; for 16h;Reflux; | e) N-(1-(5-bromo-2-fluorophenyl)-3-(tert-butyldimethylsilyloxy)-2,2-difluoropropylidene)-2-methylpropane-2-sulfinamide To a solution of 1-(5-bromo-2-fluorophenyl)-3-(tert-butyldimethylsilyloxy)-2,2-difluoropropan-1-one (16.0 g, 40.4 mmol) in dry THF (350 mL) was added Ti(OEt)4 (16.7 mL, 80.4 mmol) and 2-Methyl-2-propane sulfonamide (5.8 g, 48.4 mmol) and refluxed for 16 h. Reaction mixture was concentrated under reduced pressure and the crude residue was directly purified by column chromatography on silica gel with 3% ethyl acetate in Hexane to furnish title compound as a colorless liquid. Yield=13.1 g (65.5%). TLC (10% ethyl acetate in Hexane): Rf=0.2), LCMS RtH8=2.29 [M+H]+=499.9, 501.8, 1H NMR (300 MHz, CDCl3) delta 7.48-7.29 (m, 2H, 6.98 (m, 1H), 4.10 (t, 1H), 1.23 (d, 9H), 0.96 (d, 9H), 0.5 (d, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83.2% | With caesium carbonate; In butan-1-ol; at 80 - 90℃; for 7h;Product distribution / selectivity; | Example 6-2 To Compound 3C (10.0 g, 37.8 mmol) was added N, N-dimethylacetamide (30 mL). The reaction solution was heated to 35+/-5 C, were then added methyl isobutyl ketone (30 mL) and triethylamine (1.7eq, 6.5g) to the reaction mixture. The reaction solution was cooled to 0+/-5 C, methanesulfonyl chloride (1.2eq, 5.2 g) was added dropwise for more than 60 minutes to the reaction solution. The reaction solution was reacted at the same temperature for 1 hour. Then to the reaction mixture was added water (20 mL) dropwise for about 30 minutes, the reaction mixture was extracted. The organic layer was washed with water (10 mL). The water layer was back extracted with methyl isobutyl ketone (30 mL). The extracted solution including the obtained Compound 3D was condensed under reduced pressure to 3.6W (36 g). To the n-butanol slurry (30 mL) in t-butyl sulfonamide (2.0eq, 10.4 g) and cesium carbonate (1.5eq, 18.5 g), was added the concentrated solution including Compound 3D dropwise at 90+/-5 C for 4 hours. The reaction solution was stirred at same temperature for 3 hours, then cooled to 80 C To the reaction solution was added water (10 mL), the water layer was withdrawn from the reaction solution at 60+/-10 C. To the organic layer, was added water (30 mL) dropwise at the same temperature for 30 minutes, the mixture was cooled to 0+/-5 C. The precipitated solids were collected with filtration, the obtained solids were washed with 50% 2-propanol water (60 mL) to give 12.4g (83.2%) of Compound 3E-4. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31% | Preparative Example P71 A/-(4-Bromo-2-(trifluoromethyl)phenyl)-2-methylpropane-2-sulfonamide (P71) To a solution of 2-methylpropane-2-sulfonamide (1.00 g, 7.30 mmol) in DMF (10 ml_) was added NaH (60% w/t in mineral oil, 350 mg, 8.80 mmol) at 0C and the solution was stirred for 30 min. Then a solution of <strong>[393-37-3]4-bromo-1-fluoro-2-(trifluoromethyl)benzene</strong> (1.80 g, 7.30 mmol) in DMF (10 mL) was added and the solution was stirred at 120C overnight, cooled, diluted with H20 and extracted with EA (3x 20 mL). The combined organic phases were dried over Na2S04, filtered, concentrated and purified by CC (PE/EA = 8/1) to afford compound P71 (800 mg, 31%) as a colorless solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With tris(2,2,2-trifluoroethyl) borate; In tetrahydrofuran; at 20℃; for 96.0h;Inert atmosphere; | General procedure: The aldehyde (4.62 mmol, 1 equivalent) and 2-methylpropane-2-sulfonamide (0.76 g, 5.55 mmol, 1.2 equivalents) were dissolved in anhydrous THF (10 mL) under an atmosphere of nitrogen with stirring. The concentration of the reaction with respect to the aldehyde was 0.46 M. Tris(2,2,2-trifluoroethyl) borate (1.095 mL, 5.09 mmol) was added dropwise to the stirred reaction mixture at room temperature and the reaction was stirred for approximatively 4 days or until UPLC analysis indicated the reaction was complete. The reaction mixture was diluted with EtOAc (50 mL), washed sequentially with a saturated aqueous solution of NaHCO3 (35 mL) and water (35 mL). The organic layer was then dried over magnesium sulfate, filtered and concentrated under reduced pressure to afford the product tert-butyl sulfonyl imines. Some of the products were prone to hydrolysis and unstable to flash chromatography, so were used directly in the subsequent cyclisation step unless specified. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With 1-methyl-pyrrolidin-2-one; potassium carbonate; at 40 - 100℃; | Dissolve <strong>[2875-18-5]2,3,5,6-tetrafluoropyridine</strong> (151g) in 100gN-methylpyrrolidone,Slowly add 130g of potassium carbonate,Then a solution of tert-butylsulfonamide (302 g) in N-methylpyrrolidone was added.Stir at room temperature for a period of time, heat to 40-50 C for 1 h,The temperature was further raised to 80-100 C for 10-16 h.The liquid phase chromatography (LC) is used to control the reaction of the raw materials, and the reaction is stopped.Cool down, add 2400g water, extract three times with 500g DCM,The organic phase was adjusted to pH=5-6 with 1500 g of 3M hydrochloric acid, and the liquid was separated.The organic phase is washed once with sodium bicarbonate solution and once with water.It was evaporated to dryness to give 380 g of Compound I (yield: 99%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With copper(l) iodide; potassium carbonate; In N,N-dimethyl-formamide; at 100℃; | A mixture of <strong>[1483-56-3]2-bromo-5-(trifluoromethyl)benzoic acid</strong> (6.5 g, 24 mmol), 2-methylpropane-2-sulfonamide (4.6 g, 34 mmol), copper(I) iodide (0.92 g, 4.8 mmol), and potassium carbonate (8.4 g, 61 mmol) in N,N-dimethylformamide (DMF, 60 mL) was heated at 100 C. overnight. Upon cooling, the mixture was diluted with water and was acidified with hydrochloric acid. The mixture was extracted three times with ethyl acetate. The combined extracts were washed with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel) to provide the desired intermediate. LCMS-ESI- (m/z): [M-H]- calcd 324.06; found 324.05 |
Tags: 34813-49-5 synthesis path| 34813-49-5 SDS| 34813-49-5 COA| 34813-49-5 purity| 34813-49-5 application| 34813-49-5 NMR| 34813-49-5 COA| 34813-49-5 structure
[ 669008-26-8 ]
1-Methylcyclopropane-1-sulfonamide
Similarity: 0.82
[ 669008-26-8 ]
1-Methylcyclopropane-1-sulfonamide
Similarity: 0.82
[ 681808-56-0 ]
1-Ethylcyclopropane-1-sulfonamide
Similarity: 0.77
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :